Capricor Therapeutics Inc (CAPR)
SG&A Expense Growth
53.02%
Fiscal year · Period ending:
CAPR SG&A Expense Growth
Latest reported53.02%period ending
Latest reported53.02%period ending
CAPR FY SG&A Growth (YoY) (0.00% → 53.02%)
Latest values, visible window
High-resolution chart · PNG
CAPR sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 53.0172% | |
| 16.0748% | |
| 22.7761% | |
| 37.0402% | |
| 37.3262% | |
| 54.102% | |
| -27.0659% | |
| 3.5482% | |
| -3.4462% | |
| 12.8266% | |
| 44.9186% | |
| 36.5776% | |
| 37.0593% | |
| -23.8682% | |
| -4.338% | |
| -35.2356% | |
| -12.8761% | |
| -12.4163% | |
| 2,399.386% | |
| 849.9178% | |
| -0.6113% | |
| 3.4676% | |
| -37.3236% | |
| 31.6967% | |
| 112.9985% | |
| 0% | |
| 0% |